Robert A. Hromas

Affiliations: 
Indiana University, Bloomington, Bloomington, IN, United States 
Area:
Biochemistry, Molecular Biology, Immunology
Google:
"Robert Hromas"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wu Y, Lee SH, Williamson EA, et al. (2015) EEPD1 Rescues Stressed Replication Forks and Maintains Genome Stability by Promoting End Resection and Homologous Recombination Repair. Plos Genetics. 11: e1005675
Shanmugam I, Abbas M, Ayoub F, et al. (2014) Ubiquitin-specific peptidase 20 regulates Rad17 stability, checkpoint kinase 1 phosphorylation and DNA repair by homologous recombination. The Journal of Biological Chemistry. 289: 22739-48
Cogle CR, Goldman DC, Madlambayan GJ, et al. (2014) Functional integration of acute myeloid leukemia into the vascular niche. Leukemia. 28: 1978-87
Libby E, Garcia D, Quintana D, et al. (2014) Disease-specific survival for patients with multiple myeloma: Significant improvements over time in all age groups Leukemia and Lymphoma. 55: 2850-2857
Mohapatra S, Yannone SM, Lee SH, et al. (2013) Trimming of damaged 3' overhangs of DNA double-strand breaks by the Metnase and Artemis endonucleases. Dna Repair. 12: 422-32
Hromas R, Abkowitz JL, Keating A. (2012) Facing the NIH funding crisis: how professional societies can help. Jama. 308: 2343-4
Williamson EA, Damiani L, Leitao A, et al. (2012) Targeting the transposase domain of the DNA repair component metnase to enhance chemotherapy Cancer Research. 72: 6200-6208
Hromas R, Williamson EA, Fnu S, et al. (2012) Chk1 phosphorylation of Metnase enhances DNA repair but inhibits replication fork restart. Oncogene. 31: 4245-54
Oprea TI, Bauman JE, Bologa CG, et al. (2011) Drug Repurposing from an Academic Perspective. Drug Discovery Today. Therapeutic Strategies. 8: 61-69
Ponder J, Yoo BH, Abraham AD, et al. (2011) Neoamphimedine circumvents metnase-enhanced DNA topoisomerase IIα activity through ATP-competitive inhibition. Marine Drugs. 9: 2397-408
See more...